PRR19
gene geneOn this page
Also known as MGC70924
Summary
PRR19 (proline rich 19, HGNC:33728) is a protein-coding gene on chromosome 19q13.2, encoding Proline-rich protein 19 (A6NJB7). Promotes meiotic crossing over formation through its interaction with CNTD1 by participating in the crossover differentiation step of crossover-specific recombination intermediates.
Predicted to be involved in meiotic cell cycle. Predicted to be located in chromosome and nucleus.
Source: NCBI Gene 284338 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_199285
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33728 |
| Approved symbol | PRR19 |
| Name | proline rich 19 |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC70924 |
| Ensembl gene | ENSG00000188368 |
| Ensembl biotype | protein_coding |
| OMIM | 621177 |
| Entrez | 284338 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 protein_coding
ENST00000341747, ENST00000499536, ENST00000595750, ENST00000598490, ENST00000894985, ENST00000894986, ENST00000916535, ENST00000916536, ENST00000916537
RefSeq mRNA: 1 — MANE Select: NM_199285
NM_199285
CCDS: CCDS33036
Canonical transcript exons
ENST00000341747 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001379929 | 42309579 | 42310185 |
| ENSE00001402273 | 42302132 | 42302503 |
| ENSE00002321397 | 42310271 | 42310814 |
Expression profiles
Bgee: expression breadth ubiquitous, 154 present calls, max score 88.15.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9414 / max 28.8694, expressed in 533 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176141 | 0.8633 | 525 |
| 176142 | 0.0239 | 9 |
| 176143 | 0.0211 | 7 |
| 176144 | 0.0205 | 7 |
| 208842 | 0.0125 | 6 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.15 | gold quality |
| left testis | UBERON:0004533 | 83.70 | gold quality |
| right testis | UBERON:0004534 | 83.52 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 82.79 | gold quality |
| kidney epithelium | UBERON:0004819 | 82.06 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 81.89 | gold quality |
| testis | UBERON:0000473 | 80.85 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.60 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 75.47 | gold quality |
| cortical plate | UBERON:0005343 | 74.23 | gold quality |
| sperm | CL:0000019 | 73.94 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 72.63 | gold quality |
| ventricular zone | UBERON:0003053 | 72.21 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.80 | gold quality |
| myocardium | UBERON:0002349 | 71.70 | gold quality |
| endothelial cell | CL:0000115 | 69.00 | gold quality |
| putamen | UBERON:0001874 | 68.36 | gold quality |
| vastus lateralis | UBERON:0001379 | 68.31 | gold quality |
| prefrontal cortex | UBERON:0000451 | 68.28 | gold quality |
| nucleus accumbens | UBERON:0001882 | 68.15 | gold quality |
| quadriceps femoris | UBERON:0001377 | 68.00 | gold quality |
| gingival epithelium | UBERON:0001949 | 67.85 | gold quality |
| caudate nucleus | UBERON:0001873 | 67.19 | gold quality |
| upper arm skin | UBERON:0004263 | 66.85 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 66.37 | gold quality |
| oocyte | CL:0000023 | 66.29 | silver quality |
| superficial temporal artery | UBERON:0001614 | 66.18 | gold quality |
| gingiva | UBERON:0001828 | 65.77 | gold quality |
| secondary oocyte | CL:0000655 | 65.37 | gold quality |
| stromal cell of endometrium | CL:0002255 | 65.22 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 9.23 |
| E-ENAD-27 | no | 3.85 |
| E-ANND-3 | no | 1.84 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Prr19 | ENSMUSG00000058741 |
| rattus_norvegicus | Prr19 | ENSRNOG00000043154 |
Protein
Protein identifiers
Proline-rich protein 19 — A6NJB7 (reviewed: A6NJB7)
All UniProt accessions (2): A6NJB7, M0QXP7
UniProt curated annotations — full annotation on UniProt →
Function. Promotes meiotic crossing over formation through its interaction with CNTD1 by participating in the crossover differentiation step of crossover-specific recombination intermediates.
Subunit / interactions. Interacts with CNTD1.
Subcellular location. Nucleus. Chromosome.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A6NJB7-1 | 1 | yes |
| A6NJB7-2 | 2 |
RefSeq proteins (1): NP_954979* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029355 | Pro-rich_19 | Family |
Pfam: PF15455
UniProt features (9 total): region of interest 4, compositionally biased region 2, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NJB7-F1 | 53.19 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 16 (showing top):
GOBP_MEIOTIC_CELL_CYCLE, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, SRC_UP.V1_DN, ZNF563_TARGET_GENES, GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN, GOBP_SEXUAL_REPRODUCTION, GOBP_REPRODUCTIVE_PROCESS, chr19q13, GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN, GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN, GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN, GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP, GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP, GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP
GO Biological Process (1): meiotic cell cycle (GO:0051321)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), chromosome (GO:0005694)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
194 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRR19 | ANKRA2 | Q9H9E1 | 826 |
| PRR19 | TMEM145 | Q8NBT3 | 656 |
| PRR19 | RFXANK | O14593 | 650 |
| PRR19 | LRP2 | P98164 | 639 |
| PRR19 | PAFAH1B3 | Q15102 | 629 |
| PRR19 | C3orf70 | A6NLC5 | 514 |
| PRR19 | CCDC73 | Q6ZRK6 | 497 |
| PRR19 | CNTD1 | Q8N815 | 477 |
| PRR19 | DEDD2 | Q8WXF8 | 477 |
| PRR19 | ZNF607 | Q96SK3 | 471 |
| PRR19 | ZNF574 | Q6ZN55 | 447 |
| PRR19 | RNF212 | Q495C1 | 432 |
| PRR19 | ANK1 | P16157 | 423 |
| PRR19 | ANK3 | Q12955 | 423 |
| PRR19 | ANK2 | Q01484 | 423 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MEOX2 | PRR19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT31 | PRR19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRR19 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRR19 | SERPINB8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (14): PRR19 (Two-hybrid), PRR19 (Two-hybrid), PRR19 (Two-hybrid), PRR19 (Two-hybrid), PRR19 (Two-hybrid), PRR19 (Two-hybrid), PRR19 (Two-hybrid), CYSRT1 (Two-hybrid), PDCD6 (Two-hybrid), SERPINB8 (Affinity Capture-MS), HIBCH (Affinity Capture-MS), PRR19 (Negative Genetic), PRR19 (Two-hybrid), PRR19 (Two-hybrid)
ESM2 similar proteins: A0A1B0GVZ6, A5D7I0, A6H7B4, A6NDZ8, A6NE82, A6NJ08, A6NJB7, A6NJI1, A6NL46, A6QP24, A8MUA0, A8MUI8, A8MV72, A8MX80, B2RW88, O94850, P0C6A0, P24097, P50617, Q0P5M0, Q0VD86, Q2KIL8, Q3B8N5, Q3SY00, Q3SYA9, Q3UN58, Q5BMD4, Q5JTZ5, Q5RBE4, Q5VZ46, Q66MI6, Q68US1, Q6GQV0, Q6PAC4, Q80TS7, Q80VY2, Q8BFY7, Q8BII1, Q8IXW0, Q8K2F3
Diamond homologs: A6NJB7, B2RW88, Q0P5M0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 57 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
699 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:42302230:A:AC | donor_gain | 1.0000 |
| 19:42302231:C:CC | donor_gain | 1.0000 |
| 19:42302263:T:TA | donor_gain | 1.0000 |
| 19:42302500:GGAG:G | donor_gain | 1.0000 |
| 19:42302501:GAG:G | donor_gain | 1.0000 |
| 19:42302501:GAGG:G | donor_gain | 1.0000 |
| 19:42302504:GTA:G | donor_loss | 1.0000 |
| 19:42309570:A:AG | acceptor_gain | 1.0000 |
| 19:42309571:T:G | acceptor_gain | 1.0000 |
| 19:42309572:A:AG | acceptor_gain | 1.0000 |
| 19:42309573:T:G | acceptor_gain | 1.0000 |
| 19:42309577:A:AG | acceptor_gain | 1.0000 |
| 19:42309577:A:AT | acceptor_loss | 1.0000 |
| 19:42309578:G:GC | acceptor_gain | 1.0000 |
| 19:42309578:GGA:G | acceptor_gain | 1.0000 |
| 19:42309578:GGAC:G | acceptor_gain | 1.0000 |
| 19:42309578:GGACA:G | acceptor_gain | 1.0000 |
| 19:42302230:AC:A | donor_gain | 0.9900 |
| 19:42302231:CC:C | donor_gain | 0.9900 |
| 19:42302231:CCA:C | donor_gain | 0.9900 |
| 19:42302504:G:GG | donor_gain | 0.9900 |
| 19:42309577:AG:A | acceptor_gain | 0.9900 |
| 19:42309578:GG:G | acceptor_gain | 0.9900 |
| 19:42302240:T:TA | donor_gain | 0.9800 |
| 19:42302260:ACGT:A | donor_gain | 0.9800 |
| 19:42302261:CGTC:C | donor_gain | 0.9800 |
| 19:42302482:G:T | donor_gain | 0.9800 |
| 19:42302486:G:GT | donor_gain | 0.9800 |
| 19:42307031:C:G | donor_gain | 0.9800 |
| 19:42309576:CAGGA:C | acceptor_gain | 0.9800 |
AlphaMissense
2269 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:42310717:T:C | F350L | 0.990 |
| 19:42310719:T:A | F350L | 0.990 |
| 19:42310719:T:G | F350L | 0.990 |
| 19:42309775:T:A | I64K | 0.989 |
| 19:42310526:T:C | L286S | 0.989 |
| 19:42310711:T:A | W348R | 0.989 |
| 19:42310711:T:C | W348R | 0.989 |
| 19:42309829:A:T | K82I | 0.987 |
| 19:42309830:A:C | K82N | 0.985 |
| 19:42309830:A:T | K82N | 0.985 |
| 19:42310516:T:C | F283L | 0.985 |
| 19:42310518:T:A | F283L | 0.985 |
| 19:42310518:T:G | F283L | 0.985 |
| 19:42309775:T:C | I64T | 0.984 |
| 19:42310065:T:C | F161L | 0.983 |
| 19:42310067:C:A | F161L | 0.983 |
| 19:42310067:C:G | F161L | 0.983 |
| 19:42310529:A:T | K287I | 0.983 |
| 19:42309775:T:G | I64R | 0.981 |
| 19:42310537:T:A | W290R | 0.980 |
| 19:42310537:T:C | W290R | 0.980 |
| 19:42310713:G:C | W348C | 0.979 |
| 19:42310713:G:T | W348C | 0.979 |
| 19:42310718:T:C | F350S | 0.979 |
| 19:42309814:T:C | F77S | 0.977 |
| 19:42310117:T:C | L178S | 0.977 |
| 19:42309850:T:C | L89P | 0.976 |
| 19:42310530:A:C | K287N | 0.976 |
| 19:42310530:A:T | K287N | 0.976 |
| 19:42309792:A:C | S70R | 0.974 |
dbSNP variants (sampled 300 via entrez): RS1000307575 (19:42306367 G>T), RS1001405277 (19:42302645 C>G), RS1001438251 (19:42303064 G>T), RS1001524274 (19:42311292 T>C), RS1001545733 (19:42306222 G>A), RS1001576546 (19:42304110 T>A), RS1001944551 (19:42307474 C>G), RS1001977158 (19:42307714 C>A,T), RS1001994172 (19:42304289 A>G), RS1002021369 (19:42311145 G>A), RS1002277888 (19:42301073 C>T), RS1002281246 (19:42304506 A>C,G), RS1002491495 (19:42301363 C>T), RS1002611111 (19:42307344 C>T), RS1003075628 (19:42304156 C>G,T)
Disease associations
OMIM: gene MIM:621177 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| entinostat | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Amiodarone | increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.